The Heart Rhythm Society, in partnership with Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), is proud to announce a call for grant applications to support innovation and advancement in atrial fibrillation and stroke prevention research aimed at addressing National Quality Improvement (QI) priorities via demonstration projects/research. Through this effort, BIPI is providing $500,000 to support multiple grants to eligible applicants for proposals that aim to affect the behaviors and performance of patients, providers, and/or systems that when combined with existing standards and approaches to care, may enhance patient outcomes. Click here for more information.
Grant Opportunity for AFib and Stroke Prevention Research
Submitted by StethoAdmin on Fri, 03/18/2016 - 01:40